Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.

A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.

A new study published in Scientific Reports this October suggests that the asthma treatments omalizumab, benralizumab and mepolizumab are linked to a higher risk of anaphylactic reactions than other similar drugs.

Several studies have now been published to provide the prevalence estimates of food allergy and food sensitisation to the most common foods in Europe – cow’s milk, egg, wheat, soy, peanut, tree nuts, fish and shellfish.

A new article by Dr Paul Turner, an eminent authority on allergies at Imperial College, London and member of the Anaphylaxis UK Clinical & Scientific Panel states that the risk of a reaction for an individual with a food allergy on

A new position paper from the European Academy of Allergy and Clinical Immunology, titled “Allergy to Stings and Bites from Rare or Locally Important Arthropods: Worldwide Distribution, Available Diagnostics, and Treatment,” offers detailed information for healthcare professionals on insect stings and bites and their potential to trigger serious systemic allergic reactions.  

Adrenaline auto-injectors (AAIs) allow people to self-administer adrenaline in an anaphylaxis emergency safely and effectively. However, recent research has highlighted how often people accidentally inject themselves in the thumb or finger instead of the correct site, which is the upper, outer thigh.  

This review entitled “Innovations in the treatment of anaphylaxis: A review of recent data” explores innovative nasal and oral products under investigation for the outpatient emergency treatment of anaphylaxis.

An article published in the Journal of Allergy and Clinical Immunology this month sheds new light on the management of immediate hypersensitivity reactions to vaccines.